Download PDF
Aktuelle Dermatologie 2016; 42(08/09): 353-356
DOI: 10.1055/s-0042-107268
Kasuistik
© Georg Thieme Verlag KG Stuttgart · New York

Ausgedehntes Schwimmbadgranulom unter Adalimumab-Therapie wegen rheumatoider Arthritis

Extensive Swimming Pool Vesiculobullous Granuloma During Adalimumab Therapy of Rheumatoid Arthritis
L. Kowalzick
1   Klinik für Hautkrankheiten und Allergologie, Helios Vogtland-Klinikum Plauen GmbH
,
C. Baumann
2   Praxis für Innere Medizin und Rheumatologie, Plauen
,
A. Monecke
3   Institut für Pathologie, Universitätsklinikum Leipzig
,
C. Bielfeld
1   Klinik für Hautkrankheiten und Allergologie, Helios Vogtland-Klinikum Plauen GmbH
,
L. Eickenscheidt
1   Klinik für Hautkrankheiten und Allergologie, Helios Vogtland-Klinikum Plauen GmbH
› Author Affiliations
Further Information

Publication History

Publication Date:
13 May 2016 (online)

Also available at
   Permissions and Reprints

Zusammenfassung

Wir berichten über einen 63-jährigen Patienten mit schwerer, therapierefraktärer rheumatoider Arthritis, der unter der Therapie mit dem TNF-alpha-Antagonisten Adalimumab (Humira®) nach traumatischen Ablederungen und folgendem Reinigen eines Aquariums ausgedehnte Schwimmbadgranulome mit nachgewiesener Infektion durch Mycobacterium marinum an beiden Ellenbogen und Unterarmen entwickelte.

Abstract

We report on a 63-year-old male patient with severe recalcitrant rheumatoid arthritis, who developed during adalimumab (Humira®) therapy following traumatic dermabrasion and cleaning of an aquarium extensive swimming pool granuloma with infection by mycobacterium marinum on both elbows and forearms.

 

  • Literatur

  • 1 Arend SM, Breedveld FC, van Dissel JT. TNF-alpha blockade and tuberculosis: better look before you leap. Neth J Med 2003; 61: 111-119
    PubMedGoogle Scholar
  • 2 Ribot E, Poisnel E, De Biasi C et al. Atypical Mycobacterium marinum infection (Aquarium granuloma) in a patient on TNFα antagonist therapy for psoriatic arthritis. Joint Bone Spine 2014; 81: 272-273
    CrossrefPubMedGoogle Scholar
  • 3 Kump PK, Högenauer C, Wenzl HH et al. A case of opportunistic skin infection with Mycobacterium marinum during adalimumab treatment in a patient with Crohn’s disease. J Crohns Colitis 2013; 7: e151-158
    CrossrefPubMedGoogle Scholar
  • 4 Caron J, Michot C, Fabre S et al. Aggressive cutaneous infection with Mycobacterium marinum in two patients receiving anti-tumor necrosis factor-alfa agents. J Am Acad Dermatol 2011; 65: 1060-1062
    CrossrefPubMedGoogle Scholar
  • 5 Bakker CV, Kardaun SH, Wilting KR et al. Why you should ask your patients about their fishing hobbies. Neth J Med 2013; 71: 366-368
    PubMedGoogle Scholar
  • 6 Rallis E, Koumantaki-Mathioudaki E, Frangoulis E et al. Severe sporotrichoid fish tank granuloma following infliximab therapy. Am J Clin Dermatol 2007; 8: 385-388
    CrossrefPubMedGoogle Scholar
  • 7 Steyaert S, Stappaerts G, Mareen P et al. Soft tissue infections with atypical mycobacteria in two patients with inflammatory rheumatic diseases using TNF-inhibitors and/or leflunomide. Acta Clin Belg 2011; 66: 144-147
    PubMedGoogle Scholar
  • 8 Danko JR, Gilliland WR, Miller RS et al. Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy. Scand J Infect Dis 2009; 41: 252-255
    CrossrefPubMedGoogle Scholar
  • 9 Fallon JC, Patchett S, Gulmann C et al. Mycobacterium marinum infection complicating Crohn’s disease, treated with infliximab. Clin Exp Dermatol 2008; 33: 43-45
    PubMedGoogle Scholar
  • 10 Ferreira J, Grochowsky J, Krakower D et al. Mycobacterium marinum: an increasingly common opportunistic infection in patients on infliximab. Am J Gastroenterol 2012; 107: 1268-1269
    CrossrefPubMedGoogle Scholar
  • 11 Chopra N, Kirschenbaum AE, Widman DJ. Mycobacterium marinum tenosynovitis in a patient on etanercept therapy for rheumatoid arthritis. J Clin Rheumatol 2002; 8: 265-268
    CrossrefPubMedGoogle Scholar
  • 12 Kaneko S, Seishima M, Asano Y et al. Mycobacterium marinum infection in a case of psoriasis treated with antitumor necrosis factor α antibody detected by QuantiFERON(®)-TB test. Int J Dermatol 2014; 53: e187-189
    CrossrefPubMedGoogle Scholar